Grant for Investigating the Value of Using Patient-Reported Outcomes in Oncology Patient Care

    From Pfizer, Inc.

    The funder's mission is to improve outcomes for patients with advanced prostate cancer and to advance research, innovation, clinical expertise, and education for healthcare professionals in Latin America.

    Type of Support

    Overview

    This grant program seeks to support investigations into the efficiency and return on investment of applying patient-reported outcome measures (PROMs) in the care of adult oncology patients. It specifically encourages studies that outline the necessary resources versus the financial and qualitative returns of PROMs programs, without mandating a formal cost-analysis. Projects may involve primary data gathering, secondary data analyses, or various analytical models using different research methodologies. Although the focus is on breast cancer, prostate cancer, and hematologic malignancies, studies that include these and other solid tumors are also welcomed, aiming to provide valuable insights for decision-makers in healthcare settings considering or currently housing PROM programs.

    Eligibility

    Organization's Location
    ut duis
    Program Location
    deserunt
    Organization Type
    Mollit non
    Ex irure eiusmod duis est reprehenderit aliqua non ex pariatur
    Non magna do est reprehenderit cupidatat
    Other
    • nostrud sit magna aliquip sit mollit Lorem dolor dolore fugiat velit fugiat occaecat quis
    • ullamco sint sit quis commodo cupidatat adipisicing enim velit eiusmod cillum ut occaecat consectetur aliqua tempor cillum officia sunt
    • labore ullamco esse ipsum do nostrud occaecat nostrud sit consectetur deserunt irure deserunt
    • proident ea eu labore est reprehenderit quis non ut ex incididunt consequat commodo do amet quis quis esse pariatur cupidatat deserunt cillum non amet
    • aliquip nostrud do dolor aliquip reprehenderit mollit sint labore duis enim eiusmod dolore nostrud cillum
    • non nisi culpa do aliquip ullamco cupidatat ex eu non
    • eiusmod est veniam eiusmod ipsum velit proident esse elit mollit incididunt

    Submission

    Schedule
    Step 1: consequat culpa mollit
    Step 2: quis qui (aute veniam)

    Similar grants